Pharmaceuticals, Biotechnology and Life Sciences
As deaths from powerful painkillers continue to rise, Canada is pursuing unprecedented measures to curb their use, including requiring cigarette-style warning stickers on every prescription, Health Minister Jane Philpott told Reuters.
Asit biotech has completed Phase IIa double-blind placebo-controlled clinical study in house dust mite-induced rhinoconjunctivitis.
Abzena has made application to the London Stock Exchange for the admission of 715,772 new ordinary shares of £0.002 each (‘New Ordinary Shares’) to trading on AIM.
Van Herk Investments B.V. has become owner of more than 10% of Ablynx as it has crossed the 10% threshold and now…
Vectura Group is moving on with researching and testing its VR647, a drug/device combination to treat asthma in children for the US market.
Advanced Oncotherapy said on Tuesday it will “appropriately” deal with a UK company Sinophi Healthcare, which invests in and manages hospitals in China, because it wanted to drop purchase orders made two years ago.
ImmuPharma has appointed Northland Capital Partners as its Nominated Adviser and sole broker with immediate effect. ImmuPharma is a pharmaceutical…
A swedish oncology company Oasmia Pharmaceutical AB, which works on finding cancer cures for animals and humans, said it would move its veterinary assets to the United States.
BD (Becton, Dickinson) has received the U.S. Food and Drug Administration (FDA) 510(k) clearance for the use of PleurX catheter system in certain problems like heart failure.
STADA Arzneimittel AG has named Dr. Barthold Piening as a full Member of the Executive Board with effect from July 1, 2017.